STOCK TITAN
  1. Home
  2. Sec-filings
  3. PG
  4. [Form 4] PROCTER & GAMBLE Co Insider Trading Activity

Procter & Gamble (PG) officer reports stock tax withholdings and new RSUs

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Procter & Gamble officer Aguilar Moses, the company’s Chief Research, Development & Innovation Officer, reported several equity transactions in Procter & Gamble common stock on 12/03/2025. The filing shows multiple tax-withholding transactions (coded “F”) where shares such as 221.09, 55.4, 1,076.71 and 60.43 were withheld at a price of $144.35 per share to cover taxes on restricted stock unit grants. One transaction coded “M” reflects the settlement of 55.4 restricted stock units into common shares.

After these transactions, Moses directly owned 44,735.4826 shares of common stock and also had indirect ownership of 6,808.4349 shares through a retirement plan trustee and 428.6033 shares through an international stock ownership plan trustee. The filing also reports restricted stock units, including 19.6192 units credited as dividend equivalents on 11/17/2025 and a retirement award, which will generally deliver Procter & Gamble common stock or cash upon retirement under the company’s benefit formulas.

Positive

  • None.

Negative

  • None.
Insider Aguilar Moses Victor Javier
Role Chf Rsch, Dev & Innov Officer
Type Security Shares Price Value
Exercise Restricted Stock Units 55.4 $0.00 --
Tax Withholding Common Stock 221.09 $144.35 $32K
Exercise Common Stock 55.4 $144.35 $8K
Tax Withholding Common Stock 55.4 $144.35 $8K
Tax Withholding Common Stock 1,076.71 $144.35 $155K
Tax Withholding Common Stock 60.43 $144.35 $9K
holding Common Stock -- -- --
holding Common Stock -- -- --
Grant/Award Restricted Stock Units 19.619 $0.00 --
Holdings After Transaction: Restricted Stock Units — 724.6 shares (Direct); Common Stock — 45,872.623 shares (Direct); Common Stock — 6,808.435 shares (Indirect, By Retirement Plan Trustee)
Footnotes (1)
  1. Shares withheld to cover taxes on previous Restricted Stock Unit grant. Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock and shares acquired through the issuer's dividend reinvestment plan. Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2025.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Aguilar Moses Victor Javier
(Last) (First) (Middle)
ONE PROCTER AND GAMBLE PLAZA
(Street)
CINCINNATI OH 45202
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
PROCTER & GAMBLE Co [ PG ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chf Rsch, Dev & Innov Officer
3. Date of Earliest Transaction (Month/Day/Year)
12/03/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/03/2025 F 221.09(1) D $144.35 45,872.6226(2) D
Common Stock 12/03/2025 M 55.4 A $144.35 45,928.0226 D
Common Stock 12/03/2025 F 55.4(1) D $144.35 45,872.6226 D
Common Stock 12/03/2025 F 1,076.71(1) D $144.35 44,795.9126 D
Common Stock 12/03/2025 F 60.43(1) D $144.35 44,735.4826 D
Common Stock 6,808.4349 I By Retirement Plan Trustee
Common Stock 428.6033 I International Stock Ownership Plan (Mexico) Trustee
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (3) 11/17/2025 A V 19.6192 (4) (4) Common Stock 19.6192 $0 130.3988 D
Restricted Stock Units (5) 12/03/2025 M 55.4 (4) (4) Common Stock 55.4 $0 724.6 D
Explanation of Responses:
1. Shares withheld to cover taxes on previous Restricted Stock Unit grant.
2. Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock and shares acquired through the issuer's dividend reinvestment plan.
3. Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
4. These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.
5. Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2025.
/s/ Wednesday Shipp, attorney-in-fact for Mr. Aguilar Moses 12/05/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider activity did Procter & Gamble (PG) report in this Form 4?

The report shows Chief Research, Development & Innovation Officer Aguilar Moses had several transactions on 12/03/2025, including tax-withholding share disposals and the settlement of restricted stock units into Procter & Gamble common stock.

How many Procter & Gamble (PG) shares does the insider own after the reported transactions?

Following the reported transactions, Aguilar Moses beneficially owned 44,735.4826 shares of Procter & Gamble common stock directly, plus 6,808.4349 shares through a retirement plan trustee and 428.6033 shares through an international stock ownership plan trustee.

What were the main transaction types in this Procter & Gamble (PG) Form 4?

The transactions include multiple F-coded disposals, where shares such as 221.09, 55.4, 1,076.71, and 60.43 were withheld at $144.35 per share to cover taxes on restricted stock unit grants, and an M-coded transaction converting 55.4 restricted stock units into common stock.

What restricted stock units (RSUs) are disclosed for the Procter & Gamble (PG) executive?

The filing reports restricted stock units including 19.6192 units credited as dividend equivalents on 11/17/2025, and additional RSUs related to the retirement program. These units represent contingent rights to receive Procter & Gamble common stock or cash, generally deliverable upon retirement under plan terms.

At what price were Procter & Gamble (PG) shares used to cover taxes in this Form 4?

Shares withheld to cover taxes on restricted stock unit grants were valued at $144.35 per share in the reported transactions.

What is the role of the reporting person in Procter & Gamble (PG)?

The reporting person, Aguilar Moses, is identified as an officer of Procter & Gamble serving as Chief Research, Development & Innovation Officer.